PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for March 15, 2009 Subscribe to this News Feed    
 

SurgiCare Reports Rise in the Number of Male Breast Reduction Enquiries

SurgiCare has released figures that show a rise in the number of men enquiring about breast reduction surgery

Northenden, Manchester (PRWEB) March 15, 2009 -- SurgiCare, one of the largest cosmetic surgery networks in the UK, has released figures that show the number of men enquiring about breast reduction surgery (gynaecomastia) has risen dramatically in the past year.

Data released by the cosmetic surgery (http://www.SurgiCare.co.uk/cosmetic-surgery.aspx ) company shows that the number of male breast reduction enquiries made at SurgiCare (http://www.SurgiCare.co.uk/ ) clinics has trebled in January 2009 compared to January 2008.

SurgiCare's findings are supported by figures from the British Association of Aesthetic Plastic Surgeons (Baaps), which reveal that a total of 323 male breast reduction cosmetic surgery procedures (http://www.SurgiCare.co.uk/cosmetic-surgery-and-treatments.aspx ) were carried out in 2008, up 44% from 2007.

SurgiCare's data implies that British men are becoming increasingly concerned about their appearance, with problems ranging from classical cases of gynaecomastia, to breasts enlarged by deposits of fat over the pectoral muscles.

While it is possible that increasing numbers of men are simply becoming obese in the UK and insist on taking a surgical shortcut, many Baaps members insist that this is not the only reason for the rise in male breast reduction (http://www.SurgiCare.co.uk/cosmetic-surgery/breast-reduction.aspx ) procedures. Some Baaps members point to hormonal imbalances, such as pubertal gynaecomastia, where excessive breast tissue is developed in adolescent boys, as another possible widespread cause of the ailment. SurgiCare also believes that genetic disorders such as Klinefelter's Syndrome, where a man has an extra 'X' chromosone, can contribute to excessive breast tissue while gynaecomastia can sometimes be an unfortunate side effect of drugs prescribed for the treatment of prostate cancer.

According to cosmetic surgery experts, one of the key factors in the rise of male breast reduction operations is simply increasing awareness by men with regards to their appearance and feeling the pressure to always look good, when, in the past, such issues were more commonly felt by women.

About SurgiCare
SurgiCare is one of the largest and most respected cosmetic surgery networks in the UK. SurgiCare was established more than 16 years ago by a leading professor of surgery, now its medical director, who also chairs its in-house Medical Advisory Committee.

As one of the leading UK specialists in cosmetic treatments, SurgiCare has the experience, latest therapies and the caring, professional staff to enhance a patients self-confidence by improving appearances. SurgiCare prides itself on providing an unrivalled aftercare service with all surgeons registered on the General Medical Council Specialist Register, to ensure every patient receives the best possible standard in care and results.

SurgiCare has helped more than 20,000 patients fulfil their dreams of looking and feeling their best. SurgiCare also specialise in weight loss surgery with a unique 24 month support programme and lifetime aftercare.

###

Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Mark Bury
SurgiCare
0161 945 8688
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.